XENE - Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period.
Anavex Life Sciences shares fell 10% to $6.35 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- RedHill Biopharma Ltd. (NASDAQ: RDHL) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years' market exclusivity for Talicia.
- Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.
- Tharimmune, Inc. (NASDAQ: THAR) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis.
- Asset Entities Inc. (NASDAQ: ASST) gained 34% to $0.4703 after the company announced a stock repurchase program.
- Captivision Inc. (NASDAQ: CAPT) rose 20.1% to $2.81 after surging 44% on Friday.
- Perfect Corp. (NYSE: PERF) climbed 19.7% to $2.9944. The company on Monday announced ...